Skip to search formSkip to main contentSkip to account menu

Ozurdex

National Institutes of Health

Related topics

Related topics

4 relations

Broader (1)

Dexamethasone
Dexamethasone 0.7 MG Drug Implant [Ozurdex]Dexamethasone Drug Implant [Ozurdex]Ozurdex Drug Implant Product

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Purpose: To evaluate ocular hypertension (OHT) after Ozurdex injection to determine the incidence of OHT, therapy for OHT, and… 
Review
2016
Review
2016
COMBINED VITRECTOMY AND INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Purpose: To evaluate the safety and efficacy of combining intravitreal dexamethasone implantation (Ozurdex) with pars plana… 
2015
2015
Risk Factors for Wound Leakage After Ozurdex Injection
Ozurdex is a preloaded, injectable intravitreal dexamethasone delivery system with a 22-gauge needle. We describe risk factors in… 
2015
2015
Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular…
PURPOSE To report our results concerning the safety and efficacy of repeated sustained-release dexamethasone 0.7 mg implants… 
2014
2014
Changes in Macular Function after Ozurdex for Retinal Vein Occlusion
Purpose To investigate changes in macular function after intravitreal dexamethasone implant (Ozurdex) for macular edema (ME… 
2014
2014
Penetration force, geometry, and cutting profile of the novel and old Ozurdex needle: the MONO study.
Abstract Purpose: To investigate the geometry, penetration force, and cutting profile of the novel and old needle of the drug… 
Highly Cited
2013
Highly Cited
2013
Zuverlässigkeit und Sicherheit von intravitrealen Ozurdex-Injektionen
ZusammenfassungHintergrundSeit Juli 2010 ist Ozurdex® in Deutschland für die Behandlung des Makulaödems (MÖ) von venösen… 
2012
2012
Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
PURPOSE To report a case of worsening of vitreomacular traction (VMT) after the dexamethasone intravitreal implant (Ozurdex… 
2012
2012
Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation
Purpose: To report a case of Coats’ disease managed with the dexamethasone intravitreal implant Ozurdex® (Allergan, Inc., Irvine… 
2011
2011
Steroid implant in anterior chamber of an aphakic vitrectomized eye
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)